Lili Huang Selected Research

Chalcone (Benzalacetophenone)

8/2022	Erratum: Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350].
1/2021	A synthetic chalcone derivative, compound 39, alleviates lipopolysaccharide-induced acute lung injury in mice.
6/2019	A novel chalcone derivative, L2H17, ameliorates lipopolysaccharide-induced acute lung injury via upregulating HO-1 activity.
3/2019	Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lili Huang Research Topics

Disease

60	Neoplasms (Cancer) 04/2024 - 04/2004
36	Infections 01/2024 - 05/2008
12	Inflammation (Inflammations) 12/2023 - 04/2013
11	Reperfusion Injury 04/2024 - 06/2013
10	Insulin Resistance 01/2024 - 10/2017
9	Obesity 01/2024 - 01/2017
8	Neoplasm Metastasis (Metastasis) 03/2023 - 03/2011
7	Brain Ischemia (Cerebral Ischemia) 04/2024 - 01/2018
7	COVID-19 01/2023 - 01/2020
6	Ischemic Stroke 12/2023 - 03/2019
6	Stroke (Strokes) 06/2023 - 01/2018
6	Acute Lung Injury 01/2023 - 09/2010
6	Melanoma (Melanoma, Malignant) 12/2022 - 11/2020
6	Hypoxia (Hypoxemia) 11/2021 - 03/2011
5	Cognitive Dysfunction 04/2024 - 01/2019
5	Disease Resistance 01/2024 - 09/2013
5	Neuroinflammatory Diseases 06/2023 - 01/2016
4	Sepsis (Septicemia) 12/2023 - 08/2019
4	Hemorrhage 09/2023 - 01/2009
4	Septic Shock (Toxic Shock Syndrome) 01/2023 - 01/2020
4	Choroidal Neovascularization 01/2023 - 01/2020
4	Pain (Aches) 03/2022 - 01/2020
4	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2004
4	Hyperinsulinism (Hyperinsulinemia) 01/2022 - 01/2020
4	Body Weight (Weight, Body) 01/2022 - 10/2017
4	Carcinogenesis 02/2019 - 04/2004
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2024 - 04/2020
3	Fibrosis (Cirrhosis) 02/2024 - 01/2021
3	Adenocarcinoma 12/2023 - 01/2015
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2023 - 09/2021
3	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 09/2018
3	Type 2 Diabetes Mellitus (MODY) 11/2022 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2019
3	Uterine Hemorrhage (Uterine Bleeding) 12/2021 - 01/2009
3	Neuralgia (Stump Neuralgia) 10/2021 - 01/2017
3	Edema (Dropsy) 01/2021 - 09/2010
3	Weight Loss (Weight Reduction) 01/2021 - 12/2016
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 01/2017
3	Wounds and Injuries (Trauma) 12/2020 - 11/2011
3	Atherosclerosis 01/2020 - 04/2017
3	Ischemia 03/2019 - 06/2013
3	Chronic Disease (Chronic Diseases) 05/2017 - 07/2015
2	Lung Neoplasms (Lung Cancer) 06/2024 - 01/2017
2	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 12/2023
2	Poliomyelitis (Polio) 01/2024 - 05/2023
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 10/2017
2	Osteoporosis 11/2023 - 01/2019
2	Cicatrix (Scar) 09/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2011
10	CytokinesIBA 06/2024 - 01/2017
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
9	AntioxidantsIBA 04/2024 - 01/2018
9	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2012
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 06/2012
9	RNA (Ribonucleic Acid)IBA 01/2023 - 05/2008
8	VaccinesIBA 01/2024 - 02/2010
8	Insulin (Novolin)FDA Link 01/2022 - 10/2017
7	Monoclonal AntibodiesIBA 06/2023 - 01/2017
6	LipidsIBA 01/2024 - 10/2017
6	Therapeutic UsesIBA 01/2023 - 01/2015
5	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2020
5	Hormones (Hormone)IBA 01/2024 - 01/2017
5	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2019
5	EnzymesIBA 08/2023 - 10/2017
5	LipopolysaccharidesIBA 01/2023 - 09/2010
5	Dexmedetomidine FDA Link 03/2022 - 01/2019
5	Growth Hormone (Somatotropin)IBA 01/2022 - 10/2017
4	elezanumabIBA 06/2023 - 01/2020
4	Blood Glucose (Blood Sugar)IBA 01/2023 - 12/2016
4	Polygalacturonase (Pectinase)IBA 10/2022 - 01/2018
4	Chalcone (Benzalacetophenone)IBA 08/2022 - 03/2019
4	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2009
3	AntigensIBA 03/2024 - 08/2018
3	Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2011
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 04/2004
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2019
3	LigandsIBA 01/2022 - 01/2018
3	Long Noncoding RNAIBA 01/2022 - 08/2016
3	Peptides (Polypeptides)IBA 10/2021 - 01/2017
3	GhrelinIBA 01/2021 - 09/2010
3	Ghrelin ReceptorsIBA 01/2021 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2020 - 04/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2017
3	calloseIBA 07/2015 - 06/2012
2	Photosensitizing Agents (Photosensitizers)IBA 02/2024 - 11/2021
2	oxidized low density lipoproteinIBA 01/2024 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2024 - 01/2022
2	AlginatesIBA 10/2023 - 11/2016
2	Leucine (L-Leucine)FDA Link 10/2023 - 01/2017
2	Polysaccharides (Glycans)IBA 10/2023 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 06/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2023 - 01/2023
2	Folic Acid (Vitamin M)FDA LinkGeneric 09/2023 - 01/2019

Therapy/Procedure

39	Therapeutics 03/2024 - 12/2006
8	Immunotherapy 08/2023 - 11/2020
5	Anesthesia 03/2022 - 01/2016
3	Lasers (Laser) 01/2023 - 01/2018
3	Aftercare (After-Treatment) 02/2021 - 11/2020
2	Cesarean Section (Caesarean Section) 09/2023 - 01/2022
2	Curettage 09/2023 - 01/2018